{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:50:39Z","timestamp":1786985439808,"version":"build-2736575974"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["5R01AR051598-10"],"award-info":[{"award-number":["5R01AR051598-10"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thebonejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.bone.2014.11.011","type":"journal-article","created":{"date-parts":[[2014,11,22]],"date-time":"2014-11-22T10:51:09Z","timestamp":1416653469000},"page":"23-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["SPR4-peptide alters bone metabolism of normal and HYP mice"],"prefix":"10.1016","volume":"72","author":[{"given":"Lesya V.","family":"Zelenchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Hedge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.N.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0005","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1006\/geno.2000.6235","article-title":"MEPE, a new gene expressed in bone marrow and tumors causing osteomalacia","volume":"67","author":"Rowe","year":"2000","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.bone.2014.11.011_bb0010","doi-asserted-by":"crossref","first-page":"e56749","DOI":"10.1371\/journal.pone.0056749","article-title":"MEPE-derived ASARM peptide inhibits odontogenic differentiation of dental pulp stem cells and impairs mineralization in tooth models of X-linked hypophosphatemia","volume":"8","author":"Salmon","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bone.2014.11.011_bb0015","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.bone.2012.06.022","article-title":"MEPE is a novel regulator of growth plate cartilage mineralization","volume":"51","author":"Staines","year":"2012","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00223-009-9313-z","article-title":"MEPE's diverse effects on mineralization","volume":"86","author":"Boskey","year":"2010","journal-title":"Calcif Tissue Int"},{"issue":"2","key":"10.1016\/j.bone.2014.11.011_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2014.11.011_bb0030","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1677\/joe.1.05989","article-title":"Serum MEPE-ASARM-peptides are elevated in X-linked rickets (HYP): implications for phosphaturia and rickets","volume":"183","author":"Bresler","year":"2004","journal-title":"J Endocrinol"},{"issue":"4","key":"10.1016\/j.bone.2014.11.011_bb0035","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bone.2012.01.010","article-title":"Tooth dentin defects reflect genetic disorders affecting bone mineralization","volume":"50","author":"Opsahl Vital","year":"2012","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2014.11.011_bb0040","doi-asserted-by":"crossref","first-page":"F783","DOI":"10.1152\/ajprenal.00304.2010","article-title":"ASARM peptides: PHEX-dependent & independent regulation of serum phosphate","volume":"300","author":"David","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"issue":"7","key":"10.1016\/j.bone.2014.11.011_bb0045","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/jbmr.345","article-title":"Sclerostin is a locally acting regulator of late-osteoblast\/pre-osteocyte differentiation and regulates mineralization through a MEPE-ASARM dependent mechanism","volume":"26","author":"Atkins","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"10.1016\/j.bone.2014.11.011_bb0050","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2010.091231","article-title":"Abnormal presence of the matrix extracellular phosphoglycoprotein-derived acidic serine- and aspartate-rich motif peptide in human hypophosphatemic dentin","volume":"177","author":"Boukpessi","year":"2010","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.bone.2014.11.011_bb0055","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/en.2009-0216","article-title":"Matrix extracellular phosphoglycoprotein (MEPE) is a new bone renal hormone and vascularization modulator","volume":"150","author":"David","year":"2009","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bone.2014.11.011_bb0060","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1210\/en.2007-1205","article-title":"Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYP","volume":"149","author":"Martin","year":"2008","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.bone.2014.11.011_bb0065","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bone.2006.04.012","article-title":"Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatin","volume":"39","author":"Rowe","year":"2006","journal-title":"Bone"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bone.2004.09.015","article-title":"Surface Plasmon Resonance (SPR) confirms MEPE binds to PHEX via the MEPE-ASARM-motif: a model for impaired mineralization in X-linked rickets (HYP)","volume":"36","author":"Rowe","year":"2005","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.bone.2014.11.011_bb0075","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1074\/jbc.M203250200","article-title":"Targeted disruption of the osteoblast\/osteocyte factor 45 gene (OF45) results in increased bone formation and bone mass","volume":"278","author":"Gowen","year":"2003","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.bone.2014.11.011_bb0080","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1093\/hmg\/ddt575","article-title":"Multi-stage genome-wide association meta-analyses identified two new loci for bone mineral density","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"10.1016\/j.bone.2014.11.011_bb0085","doi-asserted-by":"crossref","first-page":"E1958","DOI":"10.1210\/jc.2012-1890","article-title":"Clinical review: genome-wide association studies of skeletal phenotypes: what we have learned and where we are headed","volume":"97","author":"Hsu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.bone.2014.11.011_bb0090","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1007\/s00198-010-1296-0","article-title":"Genetic analysis of vertebral trabecular bone density and cross-sectional area in older men","volume":"22","author":"Zmuda","year":"2011","journal-title":"Osteoporos Int"},{"issue":"8","key":"10.1016\/j.bone.2014.11.011_bb0095","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1002\/jbmr.396","article-title":"Molecular disease map of bone characterizing the postmenopausal osteoporosis phenotype","volume":"26","author":"Jemtland","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.bone.2014.11.011_bb0100","doi-asserted-by":"crossref","first-page":"e13217","DOI":"10.1371\/journal.pone.0013217","article-title":"European bone mineral density loci are also associated with BMD in East-Asian populations","volume":"5","author":"Styrkarsdottir","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.bone.2014.11.011_bb0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bone.2014.04.013","article-title":"Sibling family genes and bone mineral density: association and allele-specific expression in humans","volume":"64","author":"Alam","year":"2014","journal-title":"Bone"},{"issue":"11","key":"10.1016\/j.bone.2014.11.011_bb0110","doi-asserted-by":"crossref","first-page":"e79672","DOI":"10.1371\/journal.pone.0079672","article-title":"Increased expression of matrix extracellular phosphoglycoprotein (MEPE) in cortical bone of the rat tibia after mechanical loading: identification by oligonucleotide microarray","volume":"8","author":"Reijnders","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.bone.2014.11.011_bb0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/ng.2249","article-title":"Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture","volume":"44","author":"Estrada","year":"2012","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.bone.2014.11.011_bb0120","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1210\/jc.2003-032031","article-title":"Serum levels of matrix extracellular phosphoglycoprotein (MEPE) in normal humans correlate with serum phosphorus, parathyroid hormone and bone mineral density","volume":"89","author":"Jain","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.bone.2014.11.011_bb0125","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1095-130","article-title":"A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. The HYP Consortium","volume":"11","author":"HYP-consortium","year":"1995","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1615\/CritRevEukarGeneExpr.v22.i1.50","article-title":"Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway","volume":"22","author":"Rowe","year":"2012","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0135","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/endo.130.1.1309337","article-title":"Altered proximal tubule glucose metabolism in X-linked hypophosphatemic mice","volume":"130","author":"Capparelli","year":"1992","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0140","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/BF00298998","article-title":"Altered osteoblast gluconeogenesis in X-linked hypophosphatemic mice is associated with a depressed intracellular pH","volume":"57","author":"Rifas","year":"1995","journal-title":"Calcif Tissue Int"},{"issue":"6","key":"10.1016\/j.bone.2014.11.011_bb0145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1055\/s-2002-33256","article-title":"Up-regulation of liver glucose-6-phosphatase in x-linked hypophosphatemic mice","volume":"34","author":"Xie","year":"2002","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.bone.2014.11.011_bb0150","doi-asserted-by":"crossref","first-page":"e97326","DOI":"10.1371\/journal.pone.0097326","article-title":"PHEX mimetic (SPR4-Peptide) corrects and improves HYP and wild type mice energy-metabolism","volume":"9","author":"Zelenchuk","year":"2014","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.bone.2014.11.011_bb0155","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/ng1868","article-title":"DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis","volume":"38","author":"Lorenz-Depiereux","year":"2006","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.bone.2014.11.011_bb0160","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.bone.2014.11.011_bb0165","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.090832","article-title":"Phosphorylation-dependent inhibition of mineralization by osteopontin ASARM peptides is regulated by PHEX cleavage","volume":"25","author":"Addison","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"10","key":"10.1016\/j.bone.2014.11.011_bb0170","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1359\/jbmr.080601","article-title":"MEPE-ASARM peptides control extracellular matrix mineralization by binding to hydroxyapatite \u2014 an inhibition regulated by PHEX cleavage of ASARM","volume":"23","author":"Addison","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.bone.2014.11.011_bb0175","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/jbmr.1766","article-title":"Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia","volume":"28","author":"Barros","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"7","key":"10.1016\/j.bone.2014.11.011_bb0180","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/jbmr.141","article-title":"Guidelines for assessment of bone microstructure in rodents using micro-computed tomography","volume":"25","author":"Bouxsein","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"6","key":"10.1016\/j.bone.2014.11.011_bb0185","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1002\/jbmr.5650020617","article-title":"Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee","volume":"2","author":"Parfitt","year":"1987","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 3","key":"10.1016\/j.bone.2014.11.011_bb0190","doi-asserted-by":"crossref","first-page":"S151","DOI":"10.2215\/CJN.04301206","article-title":"Histomorphometric measurements of bone turnover, mineralization, and volume","volume":"3","author":"Ott","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.bone.2014.11.011_bb0195","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"10.1016\/j.bone.2014.11.011_bb0200","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1093\/ndt\/gfq263","article-title":"Direct micropuncture evidence that matrix extracellular phosphoglycoprotein inhibits proximal tubular phosphate reabsorption","volume":"25","author":"Shirley","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.bone.2014.11.011_bb0205","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1681\/ASN.2008030315","article-title":"The phosphatonin matrix extracellular phosphoglycoprotein (MEPE) inhibits renal intestinal phosphate transport in vivo","volume":"19","author":"Marks","year":"2008","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.bone.2014.11.011_bb0210","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ndt\/gfm535","article-title":"Matrix extracellular phosphoglycoprotein causes phosphaturia in rats by inhibiting tubular phosphate reabsorption","volume":"23","author":"Dobbie","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0215","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1677\/JOE-10-0181","article-title":"Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation","volume":"207","author":"Farrow","year":"2010","journal-title":"J Endocrinol"},{"issue":"12","key":"10.1016\/j.bone.2014.11.011_bb0220","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1002\/jbmr.2003","article-title":"Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2","volume":"28","author":"Kogawa","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"1\u20132","key":"10.1016\/j.bone.2014.11.011_bb0225","first-page":"33","article-title":"Wnt signaling and osteoblastogenesis","volume":"7","author":"Bodine","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"issue":"11","key":"10.1016\/j.bone.2014.11.011_bb0230","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1210\/en.2007-0520","article-title":"Essential role of Wnt3a-mediated activation of mitogen-activated protein kinase p38 for the stimulation of alkaline phosphatase activity and matrix mineralization in C3H10T1\/2 mesenchymal cells","volume":"148","author":"Caverzasio","year":"2007","journal-title":"Endocrinology"},{"issue":"22","key":"10.1016\/j.bone.2014.11.011_bb0235","doi-asserted-by":"crossref","first-page":"21162","DOI":"10.1074\/jbc.M501900200","article-title":"Essential role of beta-catenin in postnatal bone acquisition","volume":"280","author":"Holmen","year":"2005","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.bone.2014.11.011_bb0240","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/jbmr.1661","article-title":"LRP8 mediates Wnt\/beta-catenin signaling and controls osteoblast differentiation","volume":"27","author":"Zhang","year":"2012","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.bone.2014.11.011_bb0245","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.bone.2012.10.025","article-title":"Serum uric acid plays a protective role for bone loss in peri- and postmenopausal women: a longitudinal study","volume":"52","author":"Makovey","year":"2013","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.bone.2014.11.011_bb0250","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/jbmr.286","article-title":"Serum uric acid is associated with bone health in older men: a cross-sectional population-based study","volume":"26","author":"Nabipour","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.bone.2014.11.011_bb0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jocd.2012.05.008","article-title":"Serum uric acid levels in relation to bone-related phenotypes in men and women","volume":"16","author":"Sritara","year":"2012","journal-title":"J Clin Densitom"},{"issue":"6","key":"10.1016\/j.bone.2014.11.011_bb0260","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/jbmr.1850","article-title":"Exome sequencing reveals FAM20c mutations associated with fibroblast growth factor 23-related hypophosphatemia, dental anomalies, and ectopic calcification","volume":"28","author":"Rafaelsen","year":"2013","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.bone.2014.11.011_bb0265","doi-asserted-by":"crossref","first-page":"e1002708","DOI":"10.1371\/journal.pgen.1002708","article-title":"Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice","volume":"8","author":"Wang","year":"2012","journal-title":"PLoS Genet"},{"issue":"6","key":"10.1016\/j.bone.2014.11.011_bb0270","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1177\/0300985812453177","article-title":"Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice","volume":"49","author":"Vogel","year":"2012","journal-title":"Vet Pathol"},{"issue":"6085","key":"10.1016\/j.bone.2014.11.011_bb0275","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1126\/science.1217817","article-title":"Secreted kinase phosphorylates extracellular proteins that regulate biomineralization","volume":"336","author":"Tagliabracci","year":"2012","journal-title":"Science"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328214004190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T04:14:24Z","timestamp":1717560864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328214004190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":55,"alternative-id":["S8756328214004190"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2014.11.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SPR4-peptide alters bone metabolism of normal and HYP mice","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2014.11.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}